Terminated NA INTERVENTIONAL 1-arm NCT01410903

Immunoadsorption in Patients With Severe Systemic Sclerosis

Immunoadsorption in Addition to the Established Therapy in Patients With Systemic Sclerosis

Sponsor: GWT-TUD GmbH

Updated 7 times since 2017 Last updated: Aug 18, 2015 Started: Apr 30, 2011 Primary completion: Jul 31, 2012 Completion: Aug 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

inadequately recruitment rate, funding is not secured

Other terminated trials from GWT-TUD GmbH

More terminations from GWT-TUD GmbH

This NA trial investigates Systemic Scleroderma and is currently terminated or withdrawn. GWT-TUD GmbH leads this study, which shows 7 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jan 2021 — Jul 2024 [monthly]

Terminated NA
Aug 2020 — Jan 2021 [monthly]

Terminated NA
Feb 2020 — Aug 2020 [monthly]

Terminated NA

▶ Show 2 earlier versions

Jun 2018 — Feb 2020 [monthly]

Terminated NA
Jan 2017 — Jun 2018 [monthly]

Terminated NA

First recorded

Apr 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

GWT-TUD GmbH
Miltenyi Biomedicine GmbH

Data source: GWT-TUD GmbH

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Dresden, Germany